Clinical Trials Browser

INDUSTRY × Adenocarcinoma × Erlotinib Hydrochloride × Clear all

NCT01010945 2024-11-21

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Phase 1 Completed

Adenocarcinoma